A summary overview of the new, direct, target-specific oral anticoagulants

@inproceedings{Muntingh2016ASO,
  title={A summary overview of the new, direct, target-specific oral anticoagulants},
  author={George L. Muntingh},
  year={2016}
}
For over 50 years, warfarin was the only anticoagulant available in oral form, but now the availability of direct oral anticoagulants (DOACs) has caused a paradigm shift in thrombosis management. The historical standard of care for venous thrombotic events (VTE) treatment is initiated by the administration of a parenteral anticoagulant for five days or so, followed by overlapping treatment with a vitamin K antagonist (VKA) e.g. warfarin. The parenteral anticoagulant options for VTE treatment… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Similar Papers

Loading similar papers…